Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹3,174.20
Market cap
₹25,988 Cr
Revenue (annual)
₹1,339 Cr
Net profit (annual)
₹356.3 Cr
P/E (TTM)
67.3×Sector 47.3×
Promoter holding
32.66%+0.00% QoQ
FII holding
21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:23 IST BSE
Financial Results

Acutaas Chemicals Q4 FY26 Results: Net Profit ₹134.3 Cr, Up 114.2% YoY

Acutaas Chemicals Ltd reported revenue from operations of ₹432.8 Cr (+40.3% YoY) and net profit of ₹134.3 Cr (+114.2% YoY) for Q4 FY26.

Key figure
Net profit ₹134.3 Cr · +114.2% YoY
12:22 IST BSE
Financial Results

Acutaas Chemicals Financial Results

Acutaas Chemicals Limited approved its audited standalone and consolidated financial results for the year ended March 31, 2026. The board recommended a final dividend of Rs. 2.50 per share (50%) for FY 2025-26. Additionally, Indichem INC was identified as a material subsidiary of the company.

12:17 IST BSE
Financial Results

Acutaas Chemicals Financial Results

Acutaas Chemicals Ltd approved its audited FY26 standalone and consolidated financial results. The board recommended a final dividend of Rs. 2.5 per share (50%) for FY25-26. Additionally, the company re-appointed Cost and Internal Auditors and identified Indichem INC as a material subsidiary.